EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Anthracycline-induced arrhythmias in breast cancer therapy: A meta-analysis of single-arm trials

Tao Ran, Jinyao Chen, Qiurui She, Yi Mu, Min Zhang, Min Mao, Zhong Zuo, Juan Li iD

PLOS ONE · 23.05.2024 · 19 (5) · e0303208

DOI: 10.1371/journal.pone.0303208 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift PLOS ONE, online erschienen am 23.05.2024. Verfasst von Tao Ran und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Anthracyclines, Arrhythmias, Cardiac, Breast Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Natural Science Foundation of Chongqing, the Joint Medical Research Project of Chongqing Municipal Science and Health Commission, the Chongqing Science and Health Joint Medical Research Projec.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

As of 2020, breast cancer has emerged as the predominant cause of cancer incidence globally. Anthracycline-based chemotherapy serves as a crucial element in the treatment regimen for breast cancer. However, these anthracycline-based drugs are associated with cardiac toxicity. This study represents the first clinical quantitative analysis aimed at accurately determining the incidences of arrhythmia and abnormal electrocardiogram (ECG) changes, thereby providing valuable data to bolster clinical drug usage and monitoring.

Methods

A systematic search was conducted across multiple databases including CNKI, VIP, Wanfang, PubMed, Embase, Web of Science, and the Cochrane Library. The incidence of combined arrhythmias in breast cancer patients and the associated heterogeneity were calculated using either a random effect model or a fixed effect model. Statistical analysis was performed using STATA16.

Results

The study encompassed a total of 37 articles, which included 5705 breast cancer patients undergoing anthracycline treatment. Among these patients, 2257 developed arrhythmias. The meta-analysis revealed that the incidence of anthracycline-associated arrhythmias and abnormal ECG changes in breast cancer patients was 0.41 (0.37, 0.44). Subgroup analysis indicated that the incidence of ST-T segment change was 0.19 (0.15, 0.23), the incidence of conduction block was 0.04 (0.02, 0.05), the incidence of premature beats was 0.09 (0.07, 0.11), and the incidence of atrial fibrillation was 0.04 (0.00, 0.12). Additional results are presented in Table 3.

Conclusion

This pioneering study accurately assesses the incidence of arrhythmias in breast cancer patients treated with anthracyclines. The findings provide clinicians with valuable insights into understanding and managing the cardiac toxicity associated with such treatment. Moreover, this study lays the foundation for future research exploring the mechanisms underlying these arrhythmias and potential preventative strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnthracyclinesArrhythmias, CardiacBreast NeoplasmsFemaleHumansElectrocardiographyIncidenceClinical Trials as Topic

Substanzen

Anthracyclines

Autor:innen und Institutionen

  • Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • School of the First Clinical Medical College, Chongqing Medical University, Chongqing, China.
  • School of Public Health and Management, Chongqing Medical University, Chongqing, China.
  • Department of Academic Affairs, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

ORCID-Profile: Juan Li

Förderung

  • the Natural Science Foundation of Chongqing
  • the Joint Medical Research Project of Chongqing Municipal Science and Health Commission
  • the Chongqing Science and Health Joint Medical Research Projec

Zitieren

APA

Ran, T., Chen, J., She, Q., Mu, Y., Zhang, M., Mao, M., Zuo, Z., & Li, J. (2024). Anthracycline-induced arrhythmias in breast cancer therapy: A meta-analysis of single-arm trials. PLOS ONE, 19(5), e0303208. https://doi.org/10.1371/journal.pone.0303208

Vancouver

Ran T, Chen J, She Q, Mu Y, Zhang M, Mao M, et al. Anthracycline-induced arrhythmias in breast cancer therapy: A meta-analysis of single-arm trials. PLOS ONE. 2024;19(5):e0303208. doi:10.1371/journal.pone.0303208

BibTeX
@article{Ran2024,
  author = {Ran, Tao and Chen, Jinyao and She, Qiurui and Mu, Yi and Zhang, Min and Mao, Min and Zuo, Zhong and Li, Juan},
  title = {Anthracycline-induced arrhythmias in breast cancer therapy: A meta-analysis of single-arm trials},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {5},
  pages = {e0303208},
  doi = {10.1371/journal.pone.0303208}
}
Kostenlos starten →